Structure Therapeutics (GPCR) Shares Outstanding (2022 - 2026)
Quarterly Shares Outstanding rose 23.52% to $213.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $213.2 million through Mar 2026, up 23.52% year-over-year, with the annual reading at $212.5 million for FY2025, 23.65% up from the prior year.
Structure Therapeutics' Shares Outstanding history spans 5 years, with the latest figure at $213.2 million for Q1 2026.
- Shares Outstanding came in at $213.2 million for Q1 2026, roughly flat from $212.5 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $213.2 million in Q1 2026 to a low of $7.4 million in Q2 2023.
- The 5-year median for Shares Outstanding is $139.9 million (2024), against an average of $118.8 million.
- Year-over-year, Shares Outstanding skyrocketed 1222.5% in 2023 and then grew 0.65% in 2025.
- Structure Therapeutics' Shares Outstanding stood at $10.5 million in 2022, then surged by 1222.5% to $139.2 million in 2023, then rose by 23.44% to $171.9 million in 2024, then grew by 23.65% to $212.5 million in 2025, then grew by 0.33% to $213.2 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Shares Outstanding are $213.2 million (Q1 2026), $212.5 million (Q4 2025), and $182.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 5.21 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 56.35 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 91.57 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.16 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.80 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 133.44 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 213.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Mar 31, 2026 | 213.21 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Dec 31, 2025 | 212.51 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Sep 30, 2025 | 182.03 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Jun 30, 2025 | 172.70 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Mar 31, 2025 | 172.61 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Dec 31, 2024 | 171.86 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Sep 30, 2024 | 171.76 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Jun 30, 2024 | 171.59 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Mar 31, 2024 | 139.86 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Dec 31, 2023 | 139.22 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Sep 30, 2023 | 107.72 Mn |
| Jun 30, 2023 | 107.39 Mn |
| Jun 30, 2023 | 7.41 Mn |
| Jun 30, 2023 | 7.41 Mn |
| Jun 30, 2023 | 7.41 Mn |
| Jun 30, 2023 | 7.41 Mn |
| Jun 30, 2023 | 107.39 Mn |
| Jun 30, 2023 | 107.39 Mn |
| Jun 30, 2023 | 107.39 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Mar 31, 2023 | 114.73 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Dec 31, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Sep 30, 2022 | 10.53 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Mar 31, 2022 | 10.89 Mn |